Cargando...

Novel therapies for relapsed/refractory aggressive lymphomas

Most patients with aggressive non-Hodgkin lymphoma will be cured with initial chemoimmunotherapy; however, most patients with relapsed disease will not be cured and will die as a result of their disease. In these cases, continued treatment with conventional chemotherapy is typically not of benefit a...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Hematology Am Soc Hematol Educ Program
Autor Principal: Cohen, Jonathon B.
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Hematology 2018
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6245978/
https://ncbi.nlm.nih.gov/pubmed/30504294
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!